China Isotope & Radiation Corp. Forms Audit and Risk Management Committee

China Isotope & Radiation Corp. ( (HK:1763) ) has provided an update.

China Isotope & Radiation Corporation has established an Audit and Risk Management Committee to enhance its corporate governance structure. This committee, composed of non-executive directors with expertise in finance or law, is responsible for overseeing the company’s financial audits, internal controls, and risk management, as well as ensuring compliance with environmental, social, and governance standards. The formation of this committee is expected to strengthen the board’s decision-making capabilities and improve the company’s transparency and accountability to stakeholders.

More about China Isotope & Radiation Corp.

China Isotope & Radiation Corporation is a joint stock company based in the People’s Republic of China, operating in the isotope and radiation industry. The company focuses on providing products and services related to isotopes and radiation technologies, with a market focus that includes medical, industrial, and scientific applications.

Average Trading Volume: 336,246

Technical Sentiment Signal: Buy

Current Market Cap: HK$4.16B

Find detailed analytics on 1763 stock on TipRanks’ Stock Analysis page.